FDA allows Phase 2 study extension focusing on moderate-to-severe COVID-19 patients and grants Type B meeting to discuss eligibility to Emergency Use Authorization (EUA) and Phase 3 clinical development LAU-7b is a unique oral COVID-19 antiviral candi
Globally recognized cell therapy experts to support Turnstone in advancing tumor-infiltrating lymphocyte (TIL) therapies against solid tumors NEW YORK--(BUSINESS WIRE)--#TIL--Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering th
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Rober
Common Shares Priced at US$8.00 per Share LAVAL, Quebec--(BUSINESS WIRE)--In connection with its previously announced public offering of common shares in Canada and the United States (the “Offering”), BELLUS Health Inc. (“BELLUS Health” or the
LAVAL, Quebec--(BUSINESS WIRE)--#Altasciences--Altasciences’ pharmaceutical contract manufacturing site in Philadelphia, PA, has been chosen by Respira Technologies, Inc. to manufacture proprietary drug products for the world’s first inhaled smoking c
TORONTO--(BUSINESS WIRE)--VRE Systems Inc. (“VRE”) today announced that it was acquired by private equity firm FirePower Private Equity. Financial terms of the transaction were not disclosed. Founded in 1978, VRE is a provider of products and service
Fluence will serve as SunMed’s exclusive LED provider as the cultivator retrofits its greenhouse facilities and doubles the amount of LED lighting in its upcoming expansion AUSTIN, Texas--(BUSINESS WIRE)--Fluence by OSRAM (Fluence), a leading global pr
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-b
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (“BELLUS Health” or the “Company”) (TSX and Nasdaq: BLU), announced today the filing of a preliminary prospectus supplement (the “Supplement”) to its short form base shelf prospectus dated Dec
TORONTO--(BUSINESS WIRE)--#digitalhealth--Self Care Catalysts, a digital health company that puts patients at the center of human networks, science and technology launches its Health Storylines platform globally to help patients manage their individual he
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.